⌕
Addus HomeCare Corporation · ADUS · Nasdaq
Tenet 63 · Solid
⇄ Compare
$111.70+1.16 (+1.05%)
At close: Oct 1, 2026, 4:00 PM ET

Addus HomeCare Corporation · Statistics

Cheap or expensive, strong or fragile. Every ratio ranked against its sector peers — the number we score — with its own ten-year record shown beside it for context.

75
VALUE
Cheap vs sector
discount to its peers
61
QUALITY
Decent
mid-pack profitability
55
HEALTH
Stable
manageable balance sheet
62
GROWTH
Fair
steady, not spectacular

A decent business at a cheap price for its sector: value 75, quality 61, health 55, growth 62, each a percentile within Healthcare.

On October 2, 2026 the Tenet Score and these statistics moved from the latest fiscal year to the trailing twelve months, for companies that file quarterly statements. Scores before October 2, 2026 were computed on fiscal-year figures.
Values are the trailing twelve months where a company files quarterly statements and the figure passes our check against the filings, with balance-sheet ratios from the most recent quarter; otherwise, or where a sector's figure is still under review, the latest fiscal year. Piotroski and the five-year growth rates are fiscal years. Each row names its period.track = where peers land, worse → better (direction-adjusted: right always means better)▏sector median● you are here▲ where today's value sits in the company's own ten fiscal years (context, not scored)hover any metric for its formula
75th pctilediscount to its peers
Earnings yield (EBIT/EV)Trailing twelve months: EBIT (operating income) summed over the four most recent quarters ÷ enterprise value on the current market cap, with debt, preferred stock, minority interest, cash and short-term investments from the most recent quarter's balance sheet (Greenblatt). The vendor's own earnings yield is net income to common ÷ market cap, a different figure.7.2%80th pctileEBIT, TTM through Jun 30, 2026 ÷ enterprise value at the close of Oct 1, 2026
P/E19.868th pctilePrice at the close of Oct 1, 2026 ÷ the vendor's trailing-twelve-month EPSLatest fiscal year: held in Healthcare pending the TTM check
P/B1.882nd pctileMarket cap at the close of Oct 1, 2026 ÷ book equity at Jun 30, 2026 (most recent quarter)
P/FCF13.576th pctileMarket cap at the close of Oct 1, 2026 ÷ free cash flow, TTM through Jun 30, 2026
EV / EBITDA13.670th pctileEnterprise value at the close of Oct 1, 2026 ÷ fiscal 2025 EBITDAFiscal 2025: held in Healthcare pending the TTM check
55th pctilemanageable balance sheet
Current ratio1.6923rd pctileMost recent quarter, Jun 30, 2026
Quick ratioMost recent quarter: (Cash, short-term investments and receivables) ÷ current liabilities on the most recent quarter's balance sheet, as the data vendor builds it for that quarter. Its receivables include non-trade receivables, which Tenet's balance sheet shows inside other current assets.1.4634th pctileMost recent quarter, Jun 30, 2026
Net debt / EBITDATotal debt less cash and short-term investments, over EBITDA (operating income plus depreciation and amortisation) from the filed statements. Long-term investments are not counted as cash. For some companies they include marketable securities held for more than a year.0.3×68th pctileTenet-derived Total debt less cash and short-term investments, over EBITDA (operating income plus depreciation and amortisation) from the filed statements. Long-term investments are not counted as cash. For some companies they include marketable securities held for more than a year. Computed by Tenet from the filed statements (formula house-nde.v1), because the data vendor published no value for this year.Fiscal 2025 (Dec 31, 2025)Fiscal 2025: held in Healthcare pending the TTM check
Interest coverage10.2×67th pctileFiscal 2025 (Dec 31, 2025)Fiscal 2025: held in Healthcare pending the TTM check
Debt / equity0.0584th pctileMost recent quarter, Jun 30, 2026
61st pctilemid-pack profitability
ROIC9%76th pctileown record too shortTTM through Jun 30, 2026
ROE10%69th pctileTTM through Jun 30, 2026
Gross margin32.4%13th pctileTTM through Jun 30, 2026
Net margin7.1%62nd pctileTTM through Jun 30, 2026
Income quality (CFO/NI)1.54×55th pctileTTM through Jun 30, 2026
Piotroski F7 / 986th pctileown record too shortFiscal 2025 (Dec 31, 2025)
Altman ZTrailing twelve months: Altman's bankruptcy-distance score as Tenet builds it: 1.2 × working capital ÷ total assets, plus 1.4 × retained earnings ÷ total assets, plus 3.3 × EBIT ÷ total assets, plus 0.6 × market cap at the close ÷ total liabilities, plus 1.0 × revenue ÷ total assets. EBIT and revenue are summed over the four most recent quarters and every balance is the most recent quarter's; higher is safer.6.070th pctileTTM through Jun 30, 2026
62nd pctilesteady, not spectacular
Revenue CAGR 5yThe yearly rate that compounds the oldest fiscal year's revenue into the latest one, over the true number of fiscal years between them (up to five).+13.2%54th pctileFiscal 2020 to fiscal 2025, 5 years: revenue $764.8M to $1.4B
EPS CAGR 5y+20.2%76th pctileFiscal 2020 to fiscal 2025, 5 years: 2.08 to 5.22 per share
FCF margin7.3%55th pctileFiscal 2025 (Dec 31, 2025)Fiscal 2025: held in Healthcare pending the TTM check
the receipts behind the numbers above
Greenblatt earnings yield7.2%EBIT ÷ EV The vendor's "earningsYield" is NI ÷ market cap, which is not Greenblatt's formula.
ROIC9%NOPAT ÷ invested capital The vendor's simple ROIC, not its tiny-base roic tag; withheld when a negative EBIT flips its sign.
Interest coverage10.2× EBIT ÷ interest expense, ranked within sector peers.
Percentiles computed nightly against 400 Healthcare peers from our ingested fundamentals DB · raw statements for corrected metrics. Direction-adjusted: for "lower is better" ratios (P/E, D/E…) the percentile is flipped so right always means better. The percentile is the stock's rank among sector peers, the number that is scored. The triangle marks where the current value (the trailing twelve months or the latest fiscal year, as its row names) sits in the company's own ten fiscal-year record, shown for context and never blended into the score. Computed 2026-10-02 · Not investment advice.
Methodology© 2026 Tenet Investing Inc. · Toronto, Canada

Data from Intrinio and Financial Modeling Prep.